1
|
Lin X, Xu W, Lin T. Participation in medication safety of older-adult patients with chronic disease during the transition from hospital to home: a descriptive qualitative study. BMC Geriatr 2024; 24:877. [PMID: 39455921 PMCID: PMC11515370 DOI: 10.1186/s12877-024-05468-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2023] [Accepted: 10/14/2024] [Indexed: 10/28/2024] Open
Abstract
BACKGROUND Medication safety issues occur frequently among older-adult patients with chronic diseases during the transition from the hospital to their homes. Patient participation in medication safety has been found to be an effective measure for improving patient safety. However, few studies have been conducted on the safety of older-adult patients with chronic disease during the hospital to family transition period. This study aimed to understand the experiences and perceptions of such patients regarding participation in medication safety during the hospital to family transition period and to explore the actual situation and obstacles during this period in the Chinese context. METHODS A descriptive, qualitative research approach was adopted using purposive sampling. Eighteen patients with chronic disease (aged 61-84 years) participated, all of whom were in the period of transition from hospital to home. Data were collected through semi-structured face-to-face interviews and analysed using directed qualitative content analysis. RESULTS Four themes and 12 sub-themes were identified in this study. The four themes were participation in medication decision-making, participation in medication self-management, participation support, and barriers to patient participation. CONCLUSIONS Patient participation is important in ensuring medication safety during the hospital to family transition period. This study highlights that older-adult patients' participation in medication safety includes three aspects: participation in medication decision-making, participation in medication self-management, and participation support. Health literacy, medical communication, and family care support are the key factors affecting patient participation in medication safety. Effective intervention strategies for this patient group during the transition period would target improving patients' cognition, health literacy, doctor-prescription communication, and family care support to encourage patients to be more actively involved in the process of drug treatment.
Collapse
Affiliation(s)
- Xiaoyan Lin
- The School of Nursing, Fujian Medical University, No.1 Xuefu North Road, New University District, Fuzhou, Fujian, China
| | - Weixi Xu
- The School of Nursing, Fujian Medical University, No.1 Xuefu North Road, New University District, Fuzhou, Fujian, China
| | - Ting Lin
- The School of Nursing, Fujian Medical University, No.1 Xuefu North Road, New University District, Fuzhou, Fujian, China.
| |
Collapse
|
2
|
Fu M, Zhu Y, Wei G, Yu A, Chen F, Tang Y, Wang Z, Wang G, Liu Q, Zhong C, Liu J, Zhong J, Tian P, Li D, Li X, Shi L, Guan X. Evaluation of pharmacist-led medication reconciliation at county hospitals in China: A multicentre, open-label, assessor-blinded, nonrandomised controlled study. J Glob Health 2024; 14:04058. [PMID: 38602274 PMCID: PMC11007753 DOI: 10.7189/jogh.14.04058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/12/2024] Open
Abstract
Background Due to a lack of related research, we aimed to determine the effectiveness of a pharmacist-led medication reconciliation intervention in China. Methods We conducted a multicentre, prospective, open-label, assessor-blinded, cluster, nonrandomised controlled study at six county-level hospitals, with hospital wards serving as the clusters. We included patients discharged from the sampled hospitals who were aged ≥60 years; had ≥1 studied diagnoses; and were prescribed with ≥3 medications at discharge. Patients in the intervention group received a pharmacist-led medication reconciliation intervention and those in the control group received standard care. We assessed the incidence of medication discrepancies at discharge, patients' medication adherence, and health care utilisation within 30 days after discharge. Results There were 429 patients in the intervention group (mean age = 72.5 years, standard deviation (SD) = 7.0) and 526 patients in the control group (mean age = 73.6 years, SD = 7.1). Of the 1632 medication discrepancies identified at discharge, fewer occurred in the intervention group (1.9 per patient on average) than the control group (2.6 per patient on average).The intervention significantly reduced the incidence of medication discrepancy by 9.6% (95% confidence interval (CI) = -15.6, -3.6, P = 0.002) and improved patients' medication adherence, with an absolute decrease in the mean adherence score of 2.5 (95% CI = -2.8, -2.2, P < 0.001). There was no significant difference in readmission rates between the intervention and control groups. Conclusions Pharmacist-led medication reconciliation at discharge from Chinese county-level hospitals reduced medication discrepancies and improved patients' adherence among patients aged 60 years or above, though no impact on readmission after discharge was observed. Registration ChiCTR2100045668.
Collapse
Affiliation(s)
- Mengyuan Fu
- Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
| | - Yuezhen Zhu
- Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
- Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Chaoyang District, Beijing, China
| | - Guilin Wei
- Department of Pharmacy, The First Affiliated Hospital of Gannan Medical University, Jiangxi, China
| | - Aichen Yu
- Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
| | - Fanghui Chen
- Department of Pharmacy, The First Affiliated Hospital of Gannan Medical University, Jiangxi, China
| | - Yuanpeng Tang
- Department of Pharmacy, The First Affiliated Hospital of Gannan Medical University, Jiangxi, China
| | - Zining Wang
- Department of Pharmacy, Peking University First Hospital, Beijing, China
| | - Guoying Wang
- Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
| | - Qingpeng Liu
- Department of Pharmacy, The Peoples’ Hospital of Yudu County, Jiangxi, China
| | - Chunyuan Zhong
- Department of Pharmacy, The Peoples’ Hospital of Xingguo County, Jiangxi, China
| | - Jinghong Liu
- Department of Pharmacy, The First People’s Hospital of Longnan City, Jiangxi, China
| | - Jie Zhong
- Department of Pharmacy, The People’s Hospital of Ruijin City, Jiangxi, China
| | - Ping Tian
- Department of Pharmacy, The People’s Hospital of Shangyou County, Jiangxi, China
| | - Debao Li
- Department of Pharmacy, The People’s Hospital of Xinfeng County, Jiangxi, China
| | - Xixi Li
- International Research Center for Medicinal Administration, Peking University, Beijing, China
| | - Luwen Shi
- Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
- International Research Center for Medicinal Administration, Peking University, Beijing, China
| | - Xiaodong Guan
- Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
- International Research Center for Medicinal Administration, Peking University, Beijing, China
| |
Collapse
|